<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Mon, 03 Nov 2025 16:35:19 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Women Less Likely to Receive Heart Transplant</title><link>https://www.medscape.com/viewarticle/women-less-likely-receive-heart-transplant-yet-achieve-2025a1000u7v?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Medscape Medical News</description><pubDate>Mon, 03 Nov 2025 20:32:55 GMT</pubDate></item><item><title>Sweeteners Transform Both Weight Loss and Gut Health</title><link>https://www.medscape.com/viewarticle/sweeteners-transform-both-weight-loss-and-gut-health-2025a1000u7f?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>Replacing sugars with sweeteners and sweetness enhancers supported weight loss maintenance and improved gut microbiota composition in adults with over...</description><pubDate>Mon, 03 Nov 2025 18:44:10 GMT</pubDate></item><item><title>UK Regulator Targets Delays in Rare Disease Treatments</title><link>https://www.medscape.com/viewarticle/uk-regulator-targets-delays-rare-disease-treatments-2025a1000u74?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>The MHRA plans a flexible new framework to speed up access to treatments for rare diseases, addressing long delays and complex regulatory hurdles. Med...</description><pubDate>Mon, 03 Nov 2025 17:36:38 GMT</pubDate></item><item><title>Self-Injected Med Shows Rapid, Sustained Benefit in gMG</title><link>https://www.medscape.com/viewarticle/self-administered-med-shows-rapid-benefit-mg-2025a1000u5x?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia gravis, but long-term res...</description><pubDate>Mon, 03 Nov 2025 15:16:42 GMT</pubDate></item><item><title>Systemic Therapy for Sj√∂gren Closer With Phase 3 Success</title><link>https://www.medscape.com/viewarticle/systemic-treatment-sj%C3%B6gren-disease-closer-successful-2025a1000u37?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Current treatment options have been limited to symptom control. Telitacicept, a novel fusion protein, and ianalumab, a monoclonal antibody, demonstrat...</description><pubDate>Mon, 03 Nov 2025 13:24:19 GMT</pubDate></item></channel></rss>